Invalid Symbol

Stock Research for ADHD

Current Price


Latest Update:


Featured Broker: TradeStation

Get the due diligence for another stock.


ADHD Stock Chart & Research Data

The ADHD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ADHD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ADHD Due diligence Resources & Stock Charts

The ADHD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ADHD Detailed Price Forecast - CNN Money CNN View ADHD Detailed Summary - Google Finance
Yahoo View ADHD Detailed Summary - Yahoo! Finance Zacks View ADHD Stock Research & Analysis -

Stock Analysis

TradeIdeas View ADHD Trends & Analysis - Trade-Ideas Barrons View ADHD Major Holders - Barrons
NASDAQ View ADHD Call Transcripts - NASDAQ Seeking View ADHD Breaking News & Analysis - Seeking Alpha
Spotlight View ADHD Annual Report - OTC Report View ADHD OTC Short Report -
TradeKing View ADHD Fundamentals - TradeKing Charts View ADHD SEC Filings - Bar Chart
WSJ View Historical Prices for ADHD - The WSJ Morningstar View Performance/Total Return for ADHD - Morningstar
MarketWatch View the Analyst Estimates for ADHD - MarketWatch CNBC View the Earnings History for ADHD - CNBC
StockMarketWatch View the ADHD Earnings - StockMarketWatch MacroAxis View ADHD Buy or Sell Recommendations - MacroAxis
Bullish View the ADHD Bullish Patterns - American Bulls Short Pains View ADHD Short Pain Metrics -

Social Media Mentions

StockTwits View ADHD Stock Mentions - StockTwits PennyStocks View ADHD Stock Mentions - PennyStockTweets
Twitter View ADHD Stock Mentions - Twitter Invest Hub View ADHD Investment Forum News - Investor Hub
Yahoo View ADHD Stock Mentions - Yahoo! Message Board Seeking Alpha View ADHD Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ADHD - Insider Cow View Insider Transactions for ADHD - Insider Cow
CNBC View ADHD Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ADHD - OTC Markets
Yahoo View Insider Transactions for ADHD - Yahoo! Finance NASDAQ View Institutional Holdings for ADHD - NASDAQ

Stock Charts

FinViz View ADHD Stock Insight & Charts - StockCharts View ADHD Investment Charts -
BarChart View ADHD Stock Overview & Charts - BarChart Trading View View ADHD User Generated Charts - Trading View

Latest Financial News for ADHD

Arcturus Therapeutics Announces Completion of Merger with Alcobra Ltd. and Commences Trading on the Nasdaq Global Market
Posted on Thursday November 16, 2017

Combined Company Commences Trading on the Nasdaq Global Market on November 16, 2017 under the Ticker Symbol“ ARCT” Approximately $50.1 Million in Net Cash Following Closing of the Merger Ten Pipeline Programs, ...

Alcobra reports 3Q loss
Posted on Thursday November 09, 2017

On a per-share basis, the Tel Aviv, Israel-based company said it had a loss of 9 cents. The company's shares closed at $1.35. A year ago, they were trading at $1.91. _____ This story was generated by Automated ...

Alcobra Announces Third Quarter 2017 Financial Results and Provides Corporate Update
Posted on Thursday November 09, 2017

TEL AVIV, Israel, Nov. 09, 2017-- Alcobra Ltd. today announced financial results for the three and nine months ended September 30, 2017, and provided a corporate update.. Third Quarter and Recent Corporate ...

Arcturus Therapeutics to Host Key Opinion Leader Call on Advances in Delivery of Nucleic Acid Medicines on Tuesday, November 7
Posted on Thursday November 02, 2017

SAN DIEGO, Nov. 02, 2017-- Arcturus Therapeutics, Inc., a leading RNA medicines company, announced today that it will host a live R&D webcast focused on the“ Advances in Delivery of Nucleic Acid Medicines” ...

Alcobra Ltd. and Arcturus Therapeutics, Inc. Agree to Merge
GlobeNewswire (press release) - Sep 27, 2017
TEL AVIV, Israel, and SAN DIEGO, Sept. 27, 2017 (GLOBE NEWSWIRE) -- Alcobra Ltd. (NASDAQ:ADHD) and Arcturus Therapeutics, Inc., a privately held biotechnology company developing novel RNA medicines, today announced the signing of a definitive agreement ...

Arcturus Therapeutics Announces Expansion of Collaboration with Takeda ...
GlobeNewswire (press release) - Jan 17, 2018
Founded in 2013 and based in San Diego, Arcturus Therapeutics Ltd. (NASDAQ:ARCT) is an RNA medicines company with enabling technologies - UNA Oligomer chemistry and LUNAR™ lipid-mediated delivery.
Arcturus Therapeutics Ltd. (ARCT) Reaches $9.71 After 3.00% Up Move; Ares ... - Key Gazette

Arcturus Therapeutics Announces Strategic Collaboration with Johnson & Johnson ...
GlobeNewswire (press release) - Oct 19, 2017
SAN DIEGO, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Arcturus Therapeutics, Inc., a leading RNA medicines company, announced today that it has entered into a research collaboration and worldwide license agreement with Janssen Pharmaceuticals, Inc. (Janssen ...
Alcobra up 46% premarket on Arcturus/Janssen deal in HBV - Seeking Alpha
Alcobra Ltd (ADHD) Stock Fires Up To The Roof; Here's Why - Smarter Analyst

Arcturus Therapeutics and Synthetic Genomics Announce Strategic Alliance to ...
GlobeNewswire (press release) - Oct 31, 2017
SAN DIEGO, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Arcturus Therapeutics, Inc., a leading RNA medicines company, and Synthetic Genomics, Inc. announced today that they have entered into a research collaboration and worldwide license agreement to develop self ...

Enter a stock symbol to view the stock details.